Back
Biogen 10K Form
Sell
38
BIIB
Biogen
Last Price:
176.91
Seasonality Move:
5.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIIB
BIIB Financial Statistics
Sales & Book Value
| Annual Sales: | $9.84B |
|---|---|
| Cash Flow: | $805.6M |
| Price / Cash Flow: | 14.6 |
| Annual Sales: | $112.28 |
| Price / Book: | 1.58 |
Profitability
| EPS (TTM): | 11.07000 |
|---|---|
| Net Income (TTM): | $1.62B |
| Gross Margin: | $7.3B |
| Return on Equity: | 10.52% |
| Return on Assets: | 5.91% |
Biogen Earnings Forecast
Key Biogen Financial Ratios
- The Gross Profit Margin over the past 40 years for BIIB is 74.24%.
- The Selling, General & Administrative Expenses for BIIB have been equal to 25.92% of Gross Profit Margin.
- The Research & Development expenses have been 25.03% of Revenue.
- The Interest Expense is 21.26% of Operating Income.
- The Net Earning history of BIIB is 11.81% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Biogen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BIIB |
| CUSIP: | 09062X |
| Website: | biogen.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 1.26 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.2 |
|---|---|
| Forward P/E Ratio: | 10.49 |